Abstract
Several studies have demonstrated that higher levels of vitamin D are associated with better prognosis and outcomes in infectious diseases. We aimed to compare the vitamin D levels of paediatric patients with mild/moderate coronavirus disease 2019 (COVID-19) disease and a healthy control group. We retrospectively reviewed the medical records of patients who were hospitalised at our university hospital with the diagnosis of COVID-19 during the period between 25 May 2020 and 24 December 2020. The mean age of the COVID-19 patients was 10.7 ± 5.5 years (range 1–18 years); 43 (57.3%) COVID-19 patients were male. The mean serum vitamin D level was significantly lower in the COVID-19 group than the control group (21.5 ± 10.0vs. 28.0 ± 11.0 IU,P< 0.001). The proportion of patients with vitamin D deficiency was significantly higher in the COVID-19 group than the control group (44%vs.17.5%,P< 0.001). Patients with low vitamin D levels were older than the patients with normal vitamin D levels (11.6 ± 4.9vs.6.2 ± 1.8 years,P= 0.016). There was a significant male preponderance in the normal vitamin D group compared with the low vitamin D group (91.7%vs.50.8%,P= 0.03). C-reactive protein level was higher in the low vitamin D group, although the difference did not reach statistical significance (9.6 ± 2.2vs.4.5 ± 1.6 mg/l,P= 0.074). Our study provides an insight into the relationship between vitamin D deficiency and COVID-19 for future studies. Empiric intervention with vitamin D can be justified by low serum vitamin D levels.

This publication has 26 references indexed in Scilit: